|
16 Jul 2019 |
Sosei Heptares Enters Into Multi-target Research Collaboration and License Agreement With Genentech
|
|
16 Jul 2019 |
Imugene Enhances Portfolio with Compelling Oncolytic Virus from City of Hope, a Cancer Centre in Los Angeles, California
|
|
15 Jul 2019 |
AbbVie Enhances Early Stage Oncology Pipeline with Acquisition of Mavupharma
|
|
15 Jul 2019 |
Boehringer Ingelheim Acquires AMAL Therapeutics, Significantly Enriching Its Cancer Immunology Portfolio with Novel Cancer Vaccines Platform
|
|
15 Jul 2019 |
Recordati to acquire worldwide rights to Signifor® and Osilodrostat (LCI699)
|
|
15 Jul 2019 |
Gilead and Galapagos Enter Into Transformative Research and Development Collaboration
|
|
12 Jul 2019 |
Genmab and BliNK Biomedical Enter into Commercial License Agreement
|
|
11 Jul 2019 |
Report Package: Bispecific Antibodies
|
|
11 Jul 2019 |
vasopharm Closes € 9.5 million Financing Round
|
|
10 Jul 2019 |
AiCuris and Lysando join forces in the fight against antimicrobial resistance
|
|
10 Jul 2019 |
Jazz Pharmaceuticals Acquires Pre-clinical Pan-RAF Inhibitor Program from Redx Pharma
|
|
09 Jul 2019 |
Altimmune Signs Definitive Agreement to Acquire Spitfire Pharma, Inc. Adding NASH Drug Candidate to Portfolio
|
|
09 Jul 2019 |
Lyndra Therapeutics and Gilead Sciences to Collaborate on Development of Ultra-Long-Acting HIV Therapeutics
|
|
09 Jul 2019 |
Nimbus Therapeutics and Celgene Expand Alliance to Immunotherapy in Oncology
|
|
09 Jul 2019 |
IGM Biosciences Announces $102 Million Series C Financing to Advance its IgM Antibody Platform and Pipeline
|
|
09 Jul 2019 |
ADC Therapeutics Announces Final Close of Series E Financing Expansion
|
|
09 Jul 2019 |
BioNTech Raises USD 325 Million in an Upsized Series B Financing to Further Advance Individualized Immuno-Oncology Pipeline
|
|
09 Jul 2019 |
MorphoSys and Vivoryon Therapeutics Enter Agreement on Small Molecule Inhibitors of CD47-SIRP alpha Signaling in Immuno-Oncology
|
|
08 Jul 2019 |
Skyhawk Therapeutics Announces Collaboration Agreement with Merck to Discover and Develop Novel Small Molecules that Modulate RNA Splicing
|
|
08 Jul 2019 |
Skyhawk Therapeutics Announces Expansion of Collaboration Agreement with Biogen
|
|
08 Jul 2019 |
Eisai enters into collaboration research agreement with University of Dundee on targeted protein degradation toward cancer drug discovery
|
|
03 Jul 2019 |
Mundipharma announces exclusive license and supply agreement with Prestige Biopharma for Tuznue® (HD201)
|
|
03 Jul 2019 |
New partnership to advance Nosopharm’s lead candidate to clinical stage and develop second drug candidate
|
|
03 Jul 2019 |
Confo Therapeutics and DyNAbind Announce Drug Discovery Collaboration to Identify Novel GPCR-Modulating Compounds
|
|
02 Jul 2019 |
Century Therapeutics launches with USD 250M financing for induced pluripotent stem cell (iPSC) allogeneic cell therapy platform
|
